A lot of small biotech stocks have started to break down a bit over the past few weeksThis is understandable given the huge run the sector has had so far in 2017 after significantly underperforming the market in 2015 and 2016. One of the many things I like about the small biotech part of the market is that it has frequent "hiccups," enabling patie...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.